Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1192 | Thyroid cancer | ECE2018

Tyrosine kinase inhibitors in iodine-refractory thyroid cancer. Clinical experience

Marijuan Clara , Pla Begona , Aguirre Nerea , Fernandez Elena , Hernando Inigo , Jimenez Sara , Marazuela Monica , Lahera Marcos

Introduction: Tyrosine kinase inhibitors (TKIs) are used for treatment of iodine-refractory differentiated thyroid cancer (DTC) in patients with progressive advanced disease.Sorafenib and lenvatinib are the TKIs currently approved for this indication.Objective: To describe the clinical experience in patients with iodine-refractory DTC treated with TKIs in our Institution.Materials and methods: Restrospective cohort study of patient...

ea0063p527 | Diabetes, Obesity and Metabolism 2 | ECE2019

Artificial intelligence for the remote evaluation of gestational diabetes using a smartphone application (Sinedie©): Study design.

Albert Lara , Subias David , Casamitjana Laia , Mazarico Isabel , Caballero-Ruiz Estefania , Garcia-Saez Gema , Martin-Redondo Pablo , Hernando Elena , Rigla Mercedes

Background: Gestational diabetes (GD) prevalence is increasing as the obesity epidemic continues. Its management involves hospital visits every 1–2 weeks. In 2016 our team developed a web-based telemedicine platform (SineDie©). This tool operated as a clinical decision support system designed to manage the treatment of patients with GD. SineDie© automatically prescribed diet recommendations and identified the necessity of insulin treatment....